A detailed history of Beaumont Financial Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 21,246 shares of MRK stock, worth $2.34 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
21,246
Previous 21,516 1.25%
Holding current value
$2.34 Million
Previous $1.96 Million 6.73%
% of portfolio
0.18%
Previous 0.18%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $22,823 - $25,639
-270 Reduced 1.25%
21,246 $1.83 Million
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $69,714 - $79,024
-835 Reduced 3.74%
21,516 $1.96 Million
Q1 2022

May 09, 2022

SELL
$73.51 - $82.4 $16,760 - $18,787
-228 Reduced 1.01%
22,351 $1.84 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $9.73 Million - $12.2 Million
-134,623 Reduced 85.64%
22,579 $1.73 Million
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $102,215 - $112,411
-1,426 Reduced 0.9%
157,202 $11.8 Million
Q2 2021

Aug 04, 2021

SELL
$70.31 - $77.77 $102,230 - $113,077
-1,454 Reduced 0.91%
158,628 $12.3 Million
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $1.09 Million - $1.29 Million
15,877 Added 11.01%
160,082 $12.3 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $383,036 - $425,092
-5,337 Reduced 3.57%
144,205 $11.8 Million
Q3 2020

Nov 02, 2020

BUY
$73.18 - $82.95 $391,952 - $444,280
5,356 Added 3.71%
149,542 $12.4 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $3.83 Million - $4.36 Million
54,404 Added 60.6%
144,186 $11.2 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $378,892 - $525,163
5,980 Added 7.14%
89,782 $6.91 Million
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $130,644 - $147,417
1,684 Added 2.05%
83,802 $7.62 Million
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $237,369 - $258,741
3,120 Added 3.95%
82,118 $6.6 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $408,773 - $477,546
5,853 Added 8.0%
78,998 $6.62 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $171,723 - $195,860
2,468 Added 3.49%
73,145 $6.08 Million
Q4 2018

Feb 07, 2019

SELL
$65.24 - $75.71 $92,184 - $106,978
-1,413 Reduced 1.96%
70,677 $5.4 Million
Q3 2018

Nov 02, 2018

BUY
$57.69 - $67.84 $50,478 - $59,360
875 Added 1.23%
72,090 $5.11 Million
Q2 2018

Aug 06, 2018

SELL
$50.83 - $59.72 $3.66 Million - $4.3 Million
-72,035 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$50.96 - $59.23 $71,089 - $82,625
1,395 Added 1.97%
72,035 $3.92 Million
Q4 2017

Feb 05, 2018

SELL
$51.62 - $61.64 $49,710 - $59,359
-963 Reduced 1.34%
70,640 $3.98 Million
Q3 2017

Oct 31, 2017

BUY
$58.67 - $63.13 $217,959 - $234,527
3,715 Added 5.47%
71,603 $4.59 Million
Q2 2017

Aug 11, 2017

BUY
N/A
67,888
67,888 $4.35 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $279B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.